A Global Assessment of Antifungal Drug Resistance among Candida Species: A Meta-synthesis of Research Productivity and Scientific Report
Article Sidebar
Main Article Content
Abstract
Globally, the threat of microbial resistance to therapeutic drugs is increasing, with particular attention to certain microbes. Candida species are among the microbial groups eliciting serious antimycotic resistance concerns. Hence, this study provides scientific evidence of advances on antifungal drug resistance among Candida spp. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, datasets were retrieved from the Web of Science and Scopus databases to analyze the available scientific evidence between January 2002 and February 2023. Three thousand, one hundred and ninety-nine (3,199) articles related to antifungal drug resistance among Candida spp. were published within the period, with an average citation/document of 27.77. An unprecedented increase in productivity occurred from 2016 and continued throughout the COVID-19 pandemic period to date, also in 2011 and 2019, peak periods were observed. The most active author was Pfaller MA, having the highest publications (n = 75; 2.34%) and a total citation of 7,575. The Antimicrobial Agents and Chemotherapy journal ranked first among the top-most sources with 268 (8.38%) articles. Most of the authors of these publications originate from the USA, with 536 (16.80%) articles and a total citation of 30,478. A robust collaborative network was noticed among authors, institutions, and countries in the developed nations, but lacking with authors in developing regions. Only the Republic of South Africa made the list of top 20 actively collaborating countries on the subject from African region. Also, the thematic landscape of research areas lacks important topics such as the discovery of novel drug targets and diagnostic tools. This article provides a comprehensive global overview of the up-to-date research on drug resistance among Candida spp. and associated diseases. It has underscored the need for further synergistic efforts worldwide to ensure global health.
Article Details
Copyright (c) 2025 Afolabi KO, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Archives of Case Reports is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Archives of Case Reports is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
1. Onohuean H, Bright IE, Alagbonsi AI. GC-MS biocomponents characterization and antibacterial potency of ethanolic crude extracts of Camellia sinensis. SAGE Open Med. 2022;10:20503121221116859. Available from: https://doi.org/10.1177/20503121221116859
2. Onohuean H, Igere BE. Occurrence, Antibiotic Susceptibility and Genes Encoding Antibacterial Resistance of Salmonella spp. and Escherichia coli From Milk and Meat Sold in Markets of Bushenyi District, Uganda. Microbiol Insights. 2022;15:11786361221088992. Available from: https://doi.org/10.1177/11786361221088992
3. Igere BE, Hope O, Oyama G. Occurrence of New Delhi Metallo-Beta-Lactamase 1 Producing Enterococcus Species in Oghara Water Nexus: An Emerging Environmental Implications of Resistance Dynamics. Microbiol Insights. 2022;15:117863612211337. Available from: https://doi.org/10.1177/117863612211337
4. Igere BE, Onohuean H, Nwodo UU. Modern knowledge-scape possess petite influence on the factual persistence of resistance determinants (ARGs/MGEs): A map and assessment of discharged wastewater and water bodies. Heliyon. 2022;8:e12253. Available from: https://doi.org/10.1016/j.heliyon.2022.e12253
5. Fausto A, Rodrigues ML, Coelho C. The still underestimated problem of fungal diseases worldwide. Front Microbiol. 2019;10:214. Available from: https://doi.org/10.3389/fmicb.2019.00214
6. Arastehfar A, Gabaldón T, Garcia-Rubio R, Jenks JD, Hoenigl M, Salzer HJF, et al. Drug-resistant fungi: An emerging challenge threatening our limited antifungal armamentarium. Antibiotics (Basel). 2020;9(12):877. Available from: https://doi.org/10.3390/antibiotics9120877
7. Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: Human fungal infections. Sci Transl Med. 2012;4(165):165rv13. Available from: https://doi.org/10.1126/scitranslmed.3004404
8. Rhodes J. Rapid Worldwide Emergence of Pathogenic Fungi. Cell Host Microbe. 2019;26(1):12-14. Available from: https://doi.org/10.1016/j.chom.2019.06.009
9. Sweileh WM, Sawalha AF, Al-Jabi S, Zyoud SH. Bibliometric analysis of literature on antifungal triazole resistance: 1980–2015. Germs. 2017;7(1):19-27. Available from: https://doi.org/10.18683/germs.2017.1104
10. Dupont D, Tirard-Collet P, Persat F, Menotti J, Josse E, Wallon M, et al. K3-EDTA differentially inhibits the growth of Candida strains according to their azole resistance status. Med Mycol. 2021;58:514-520. Available from: https://doi.org/10.1093/MMY/MYZ080
11. • Pérez-Laguna V, Barrena-López Y, Gilaberte Y, Rezusta A. In vitro effect of photodynamic therapy with different lights and combined or uncombined with chlorhexidine on Candida spp. Pharmaceutics. 2021;13(8):1176. Available from: https://doi.org/10.3390/pharmaceutics13081176
12. • Magill SS, O'Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al. Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals. N Engl J Med. 2018;379(18):1732-1744. Available from: https://doi.org/10.1056/nejmoa1801550
13. Centers for Disease Control and Prevention (CDC). Invasive Candidiasis Statistics [Internet]. 2021 [cited 2025 May 6]. Available from: https://www.google.com/search?q=Invasive+Candidiasis+Statistics
14. Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18:e339-e347. Available from: https://doi.org/10.1016/S1473-3099(18)30103-8
15. Mikulska M, Del Bono V, Ratto S, Viscoli C. Occurrence, presentation and treatment of candidemia. Expert Rev Clin Immunol. 2012;8(8):755-765. Available from: https://doi.org/10.1586/eci.12.52
16. Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MGL, Denning DW. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother. 1994;34(5):659-668. Available from: https://doi.org/10.1093/jac/34.5.659
17. Atriwal T, Chawla M, Hussain A, Alajmi MF, Abid M. Reactive oxygen mediated apoptosis as a therapeutic approach against opportunistic Candida albicans. Adv Protein Chem Struct Biol. 2021;125:25-49. Available from: https://doi.org/10.1016/bs.apcsb.2020.12.004
18. Donadu MG, Usai D, Marchetti M, Usai M, Mazzarello V, Molicotti P, et al. Antifungal activity of oils macerates of North Sardinia plants against Candida species isolated from clinical patients with candidiasis. Nat Prod Res. 2020;34(23):3280-3284. Available from: https://doi.org/10.1080/14786419.2018.1557175
19. Berman J, Krysan DJ. Drug resistance and tolerance in fungi. Nat Rev Microbiol. 2020;18:319-331. Available from: https://doi.org/10.1038/s41579-019-0322-2
20. Denning DW. Antifungal drug resistance: an update. Eur J Hosp Pharm. 2022;29(3):119-122. Available from: https://doi.org/10.1136/ejhpharm-2020-002604
21. Jamiu AT, Albertyn J, Sebolai OM, Pohl CH. Update on Candida krusei, a potential multidrug-resistant pathogen. Med Mycol. 2021;59(1):14-30. Available from: https://doi.org/10.1093/mmy/myaa031
22. Basso V, Tran DQ, Schaal JB, Tran P, Eriguchi Y, Ngole D, et al. Rhesus Theta Defensin 1 Promotes Long Term Survival in Systemic Candidiasis by Host Directed Mechanisms. Sci Rep. 2019;9:16905. Available from: https://doi.org/10.1038/s41598-019-53402-z
23. Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097. Available from: https://doi.org/10.1371/journal.pmed.1000097
24. Kassambara A. ggpubr: “ggplot2” Based Publication Ready Plots. R Packag. version 0.4.0. 2020. Available from: https://rpkgs.datanovia.com/ggpubr/
25. RStudio Team. RStudio: Integrated Development for R. Boston, MA: RStudio, PBC; 2020. Available from: https://doi.org/10.1145/3132847.3132886
26. Onohuean H, Agwu E, Nwodo UU. Systematic review and meta-analysis of environmental Vibrio species – antibiotic resistance. Heliyon. 2022;8:e08845. Available from: https://doi.org/10.1016/j.heliyon.2022.e08845
27. Rojas-Rodríguez AE, Rodríguez-Castillejos G, Horta-Rodríguez C, Zapata-Serna Y, Tovar-Aguirre OL, Acosta RI, et al. Resistance to anti-fungal agents in Candida albicans: Bibliometric analysis of scientific literature. Asociación Interciencia. 2022;47:138-144. Available from: https://www.redalyc.org/journal/339/33970946007/html/
28. Kaur H, Wadhwa K, Jain K, Yadav A. Multidrug-resistant Candida auris: A global challenge. J Appl Biol Biotechnol. 2021;9(1):104-113. Available from: https://doi.org/10.7324/JABB.2021.9114
29. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41-44. Available from: https://doi.org/10.1111/j.1348-0421.2008.00083.x
30. Chakrabarti A, Sood P. On the emergence, spread and resistance of Candida auris: Host, pathogen and environmental tipping points. J Med Microbiol. 2021;70(3):001318. Available from: https://doi.org/10.1099/jmm.0.001318
31. Calvo B, Melo ASA, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, et al. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016;73(4):369-374. Available from: https://doi.org/10.1016/j.jinf.2016.07.008
32. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35. Available from: https://doi.org/10.1186/s13756-016-0132-5
33. van Schalkwyk E, Mpembe RS, Thomas J, Shuping L, Ismail H, Lowman W, et al. Epidemiologic shift in candidemia driven by Candida auris, South Africa, 2016–2017. Emerg Infect Dis. 2019;25(9):1698-1707. Available from: https://doi.org/10.3201/eid2509.190040
34. Tsai CS, Lee SS, Chen WC, Tseng CH, Lee NY, Chen PL, et al. COVID-19-associated candidiasis and the emerging concern of Candida auris infections. J Microbiol Immunol Infect. 2023;56(4):672-679. Available from: https://doi.org/10.1016/j.jmii.2022.12.002
35. Kundu R, Singla N. COVID-19 and plethora of fungal infections. Curr Fungal Infect Rep. 2022;16(2):47-54. Available from: https://doi.org/10.1007/s12281-022-00432-2
36. Segrelles-Calvo G, de S Araújo GR, Llopis-Pastor E, Carrillo J, Hernández-Hernández M, Rey L, et al. Candida spp. co-infection in COVID-19 patients with severe pneumonia: Prevalence study and associated risk factors. Respir Med. 2021;188:106619. Available from: https://doi.org/10.1016/j.rmed.2021.106619
37. Afolabi KO, Iweriebor BC, Okoh AI, Obi LC. Global status of porcine circovirus type 2 and its associated diseases in Sub-Saharan Africa. Adv Virol. 2017;2017:6807964. Available from: https://doi.org/10.1155/2017/6807964
38. Albanna B, Handl J, Heeks R. Publication outperformance among global South researchers: An analysis of individual-level and publication-level predictors of positive deviance. Scientometrics. 2021;126:8375–8431. Available from: https://doi.org/10.1007/s11192-021-04128-1
39. Hameed M, Najafi M, Cheeti S, Sheokand A, Mago A, Desai S. Factors influencing international collaboration on the prevention of COVID-19. Public Health. 2022;212:95-101. Available from: https://doi.org/10.1016/j.puhe.2022.08.017
40. Zhao W, Wang L, Zhang L. How does academia respond to the burden of infectious and parasitic disease? Health Res Policy Syst. 2022;20:89. Available from: https://doi.org/10.1186/s12961-022-00889-0
41. Ros F, Kush R, Friedman C, Gil Zorzo E, Rivero Corte P, Rubin JC, et al. Addressing the COVID-19 pandemic and future public health challenges through global collaboration and a data-driven systems approach. Learn Health Syst. 2021;5:e10253. Available from: https://doi.org/10.1002/lrh2.10253
42. Rios RS, Zheng KI, Zheng MH. Data sharing during COVID-19 pandemic: what to take away. Expert Rev Gastroenterol Hepatol. 2020;14(12):1125-1130. Available from: https://doi.org/10.1080/17474124.2020.1815533
43. Ross MB, Glennon BM, Murciano-Goroff R, Berkes EG, Weinberg BA, Lane JI. Women are credited less in science than men. Nature. 2022;608(7921):135-145. Available from: https://doi.org/10.1038/s41586-022-04966-w
44. Frenk J, Gómez-Dantés O, Moon S. From sovereignty to solidarity: A renewed concept of global health for an era of complex interdependence. Lancet. 2014;383(9911):94-97. Available from: https://doi.org/10.1016/S0140-6736(13)62561-1
45. Matthews KRW, Yang E, Lewis SW, Vaidyanathan BR, Gorman M. International scientific collaborative activities and barriers to them in eight societies. Account Res. 2020;27(8):477-495. Available from: https://doi.org/10.1080/08989621.2020.1774373
46. Vervoort D, Ma X, Luc JGY. COVID-19 pandemic: A time for collaboration and a unified global health front. Int J Qual Health Care. 2021;33(1):mzaa065. Available from: https://doi.org/10.1093/intqhc/mzaa065
47. Sinan KI, Dall’acqua S, Ferrarese I, Mollica A, Stefanucci A, Glamočlija J, et al. LC-MS based analysis and biological properties of Pseudocedrela kotschyi (Schweinf.) Harms extracts: A valuable source of antioxidant, antifungal, and antibacterial compounds. Antioxidants. 2021;10(10):1570. Available from: https://doi.org/10.3390/antiox10101570
48. Uysal A, Ozer OY, Zengin G, Stefanucci A, Mollica A, Picot-Allain CMN, et al. Multifunctional approaches to provide potential pharmacophores for the pharmacy shelf: Heracleum sphondylium L. subsp. ternatum (Velen.) Brummitt. Comput Biol Chem. 2019;78:64-73. Available from: https://doi.org/10.1016/j.compbiolchem.2018.11.018
49. Coelho C, Casadevall A. Cryptococcal therapies and drug targets: the old, the new and the promising. Cell Microbiol. 2016;18(6):792-799. Available from: https://doi.org/10.1111/cmi.12590